REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,210,097 | +11.7% | 263,079 | -7.2% | 0.01% | +20.0% |
| Q1 2024 | $9,141,492 | +81.8% | 283,633 | +61.8% | 0.01% | +66.7% |
| Q4 2023 | $5,029,009 | +349.3% | 175,349 | +333.6% | 0.01% | +500.0% |
| Q3 2023 | $1,119,324 | +4.3% | 40,438 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $1,073,183 | +48.9% | 40,119 | +20.6% | 0.00% | 0.0% |
| Q1 2023 | $720,672 | +6.0% | 33,272 | +16.6% | 0.00% | 0.0% |
| Q4 2022 | $679,894 | +22.4% | 28,543 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $555,572 | +21.8% | 28,173 | +20.3% | 0.00% | 0.0% |
| Q2 2022 | $456,000 | -23.6% | 23,413 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $597,000 | +1.4% | 23,413 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $589,000 | -8.3% | 23,413 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $642,000 | -13.2% | 23,326 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $740,000 | -12.7% | 23,326 | +26.3% | 0.00% | -50.0% |
| Q1 2021 | $848,000 | +27.5% | 18,473 | +10.0% | 0.00% | +100.0% |
| Q4 2020 | $665,000 | +49.4% | 16,797 | +31.4% | 0.00% | 0.0% |
| Q3 2020 | $445,000 | – | 12,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |